BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 18277155)

  • 1. Urotensin II: a cardiovascular and renal update.
    Zoccali C; Mallamaci F
    Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):199-204. PubMed ID: 18277155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging roles of urotensin-II in cardiovascular disease.
    Russell FD
    Pharmacol Ther; 2004 Sep; 103(3):223-43. PubMed ID: 15464591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urotensin-II as a novel therapeutic target in the clinical management of cardiorenal disease.
    Gilbert RE; Douglas SA; Krum H
    Curr Opin Investig Drugs; 2004 Mar; 5(3):276-82. PubMed ID: 15083593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Urotensin II--new peptide which regulates function of cardiovascular system].
    Jołda-Mydłowska B
    Pol Merkur Lekarski; 2004 May; 16(95):474-6. PubMed ID: 15518431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of urotensin II in the metabolic syndrome.
    Ong KL; Wong LY; Cheung BM
    Peptides; 2008 May; 29(5):859-67. PubMed ID: 17610998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of urotensin II in atherosclerotic cardiovascular diseases.
    Pakala R
    Cardiovasc Revasc Med; 2008; 9(3):166-78. PubMed ID: 18606380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of urotensin II, urotensin II-related peptide and urotensin II receptor mRNAs in the cardiovascular organs of hypertensive rats: comparison with endothelin-1.
    Hirose T; Takahashi K; Mori N; Nakayama T; Kikuya M; Ohkubo T; Kohzuki M; Totsune K; Imai Y
    Peptides; 2009 Jun; 30(6):1124-9. PubMed ID: 19463745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urotensin-II and cardiovascular remodeling.
    Papadopoulos P; Bousette N; Giaid A
    Peptides; 2008 May; 29(5):764-9. PubMed ID: 17988761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of urotensin II in cardiovascular and renal physiology and diseases.
    Zhu YC; Zhu YZ; Moore PK
    Br J Pharmacol; 2006 Aug; 148(7):884-901. PubMed ID: 16783414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of urotensin II in human pathophysiology].
    Piech J; Skoczylas A
    Wiad Lek; 2008; 61(10-12):277-82. PubMed ID: 19323069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal and vascular actions of urotensin II.
    Ashton N
    Kidney Int; 2006 Aug; 70(4):624-9. PubMed ID: 16807543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal effects of human urotensin-II in rats with experimental congestive heart failure.
    Ovcharenko E; Abassi Z; Rubinstein I; Kaballa A; Hoffman A; Winaver J
    Nephrol Dial Transplant; 2006 May; 21(5):1205-11. PubMed ID: 16396970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urotensin II: evidence for cardiac, hepatic and renal production.
    Charles CJ; Rademaker MT; Richards AM; Yandle TG
    Peptides; 2005 Nov; 26(11):2211-4. PubMed ID: 16269352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urotensin II and urotensin II-related peptide (URP) in cardiac ischemia-reperfusion injury.
    Prosser HC; Forster ME; Richards AM; Pemberton CJ
    Peptides; 2008 May; 29(5):770-7. PubMed ID: 17900760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular role of urotensin II: effect of chronic infusion in the rat.
    Kompa AR; Thomas WG; See F; Tzanidis A; Hannan RD; Krum H
    Peptides; 2004 Oct; 25(10):1783-8. PubMed ID: 15476946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urotensin II and cardiovascular diseases.
    Thanassoulis G; Huyhn T; Giaid A
    Peptides; 2004 Oct; 25(10):1789-94. PubMed ID: 15476947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of urotensin II-related peptide and its receptor in kidney with hypertension or renal failure.
    Mori N; Hirose T; Nakayama T; Ito O; Kanazawa M; Imai Y; Kohzuki M; Takahashi K; Totsune K
    Peptides; 2009 Feb; 30(2):400-8. PubMed ID: 18955095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urotensin II: the old kid in town.
    Onan D; Hannan RD; Thomas WG
    Trends Endocrinol Metab; 2004; 15(4):175-82. PubMed ID: 15109617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic urotensin II infusion enhances macrophage foam cell formation and atherosclerosis in apolipoprotein E-knockout mice.
    Shiraishi Y; Watanabe T; Suguro T; Nagashima M; Kato R; Hongo S; Itabe H; Miyazaki A; Hirano T; Adachi M
    J Hypertens; 2008 Oct; 26(10):1955-65. PubMed ID: 18806619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulative effect of human urotensin-II on cardiovascular system.
    Zhou P; Li ZL; Tang CS
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Jun; 22(6):566-8. PubMed ID: 12297490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.